argenx Reports Full Year 2023 Financial Results and Provides

$374 million in fourth quarter and $1.2 billion in full year global net product salessBLA for VYVGART® Hytrulo for CIDP accepted for priority revi...

Related Keywords

Saudi Arabia , South Korea , Japan , Australia , Belgium , United States , Canada , Netherlands , Amsterdam , Noord Holland , China , France , Switzerland , United Kingdom , Israel , Ben Petok , Tim Van Hauwermeiren , Zai Lab , Regulatory Agency , Immunology Innovation Program , Instagram , Twitter , Ministry Of Health , Linkedin , Chief Executive Officer , More Patients , Biologics License Application , Prescription Drug User Fee Act , Repeatable Innovation Playbook , Drive Long Term Pipeline ,